http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103339126-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate | 2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103339126-B |
| titleOfInvention | The solid-state form of formula (I) compound and pharmaceutical composition, dosage form and using method |
| abstract | The present invention relates to [(5-chlorothiophene-2-base Herbicidal sulphonylamino formoxyl)-(4-(the fluoro-7-of 6-(methylamino)-2 of novel anhydrous crystalline Form; 4-dioxo-1; 2-dihydroquinazoline-3 (4H)-Ji) phenyl) amino potassium salt, and there is platelet ADP receptor suppression (specifically P2Y in treatment or prevention animal (specifically the mankind) 12 Suppress) disease or obstacle in purposes.The invention still further relates to the method preparing this novel crystalline forms.The invention still further relates to the solid orally ingestible of this novel crystalline forms, its preparation and application thereof. |
| priorityDate | 2010-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.